At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.
Funding
Late Stage
Current Stage
$228.59M
Total Funding
Recent News
FMOL Health Shows Drastic Reduction in Sepsis Related Deaths
Franciscan Missionaries of Our Lady Health System
Study: Cytovale’s Rapid Sepsis Test Helps Increase Safe ED Discharges
Medical Product Outsourcing
Cytovale · 1w ago
Sales Development Representative
South San Francisco, CAHybridEntry Level
Cytovale · 3w ago
Senior Clinical Data Research Engineer
United StatesRemoteSenior Level
Cytovale · 3w ago
Director of Marketing - Demand Generation
United StatesHybridDirector/Executive
Cytovale · 1m ago
Director, Business Development - MIDATLANTIC REGION
Washington, District of Columbia, United StatesHybridDirector/Executive